Mechanisms of Smell Improvement With Dupilumab
Latest Information Update: 10 Mar 2025
At a glance
- Drugs Dupilumab (Primary)
- Indications Nasal polyps; Rhinosinusitis
- Focus Therapeutic Use
- 05 Mar 2025 Status changed from recruiting to completed.
- 23 Sep 2024 Planned End Date changed from 30 Jun 2025 to 30 Jan 2025.
- 23 Sep 2024 Planned primary completion date changed from 30 Jun 2025 to 30 Jan 2025.